A Guide to Attention Metrics for Pharmaceutical Marketers

Pharma marketers face a uniquely constrained advertising landscape. Important Safety Information limits creative flexibility, niche audiences often require broader inclusion lists to achieve scale, and privacy changes continue to restrict identity-based targeting.

At the same time, metrics like viewability, VCR, and CTR offer limited insight into whether a placement is likely to create the conditions for business outcomes. Attention metrics add a more meaningful signal, helping marketers distinguish more valuable opportunities across broader inventory.

Adelaide AU focuses specifically on media placement quality, independent of audience and creative, giving pharma teams a more consistent way to compare and optimize inventory across channels. Case studies in the guide show results including 114% higher brand awareness, 60% higher ad recall, and 132% higher unaided awareness.

Inside the Guide:

• Why legacy metrics fall short for pharma’s unique media constraints
• How AU separates media quality from audience and creative
• How to maintain quality while broadening inventory
• A 6-step framework from measurement through activation
• Pharma case studies linking AU to stronger brand outcomes